FDA Import Refusal 1FX-4241563-9/20002/1 — GLP PHARMA STANDARDS
The FDA refused shipment 1FX-4241563-9/20002/1 from GLP PHARMA STANDARDS (India) on Sep 14, 2026. The refused product falls under Drugs and Biologics — ANTI-INFLAMMATORY N.E.C.. Cited charge: 75 This firm has 2 other import refusals on record.
Refusal Details
- Date
- Sep 14, 2026
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 62GDA99 ANTI-INFLAMMATORY N.E.C.
- Charges
- 75